$2.81
-0.15 (-5.07%)
Open$2.94
Previous Close$2.96
Day High$2.98
Day Low$2.71
52W High$15.70
52W Low$2.49
Volume—
Avg Volume5.54M
Market Cap421.19M
P/E Ratio—
EPS$-1.39
SectorPharmaceuticals
Analyst Ratings
Hold
17 analysts
Price Target
+1,406.0% upside
Current
$2.81
$2.81
Target
$42.32
$42.32
$27.22
$42.32 avg
$56.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.23B | 1.08B | 180.40M |
| Net Income | -162,706,958 | -129,086,973 | 49.45M |
| Profit Margin | -13.3% | -12.6% | 27.4% |
| EBITDA | -58,232,753 | -48,766,850 | 94.91M |
| Free Cash Flow | — | — | 60.57M |
| Rev Growth | +13.4% | +13.4% | -1.4% |
| Debt/Equity | 0.22 | 0.22 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |